|Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children|
JV Williams, PA Harris, SJ Tollefson, LL Halburnt-Rush, JM Pingsterhaus, ...
New England Journal of Medicine 350 (5), 443-450, 2004
|Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus|
R Xu, DC Ekiert, JC Krause, R Hai, JE Crowe, IA Wilson
Science 328 (5976), 357-360, 2010
|Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors|
X Yu, T Tsibane, PA McGraw, FS House, CJ Keefer, MD Hicar, ...
Nature 455 (7212), 532-536, 2008
|Proof of principle for epitope-focused vaccine design|
BE Correia, JT Bates, RJ Loomis, G Baneyx, C Carrico, JG Jardine, ...
Nature 507 (7491), 201-206, 2014
|Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions|
R De Alwis, SA Smith, NP Olivarez, WB Messer, JP Huynh, ...
Proceedings of the National Academy of Sciences 109 (19), 7439-7444, 2012
|Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy|
PF Wright, RA Karron, RB Belshe, J Thompson, JE Crowe Jr, TG Boyce, ...
The Journal of infectious diseases 182 (5), 1331-1342, 2000
|Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice|
G Sapparapu, E Fernandez, N Kose, B Cao, JM Fox, RG Bombardi, ...
Nature 540 (7633), 443-447, 2016
|The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience|
JV Williams, CK Wang, CF Yang, SJ Tollefson, FS House, JM Heck, ...
The Journal of infectious diseases 193 (3), 387-395, 2006
|Towards a consensus on datasets and evaluation metrics for developing B‐cell epitope prediction tools|
JA Greenbaum, PH Andersen, M Blythe, HH Bui, RE Cachau, J Crowe, ...
Journal of Molecular Recognition: An Interdisciplinary Journal 20 (2), 75-82, 2007
|Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children|
RA Karron, PF Wright, JE Crowe Jr, MLC Mann, J Thompson, M Makhene, ...
Journal of Infectious Diseases 176 (6), 1428-1436, 1997
|Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes|
AC Monsalvo, JP Batalle, MF Lopez, JC Krause, J Klemenc, ...
Nature medicine 17 (2), 195-199, 2011
|Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity|
CF Barbas, JE Crowe, D Cababa, TM Jones, SL Zebedee, BR Murphy, ...
Proceedings of the National Academy of Sciences 89 (21), 10164-10168, 1992
|Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of …|
R Martino, RP Porras, N Rabella, JV Williams, E Rámila, N Margall, ...
Biology of blood and marrow transplantation 11 (10), 781-796, 2005
|A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections|
JV Williams, R Martino, N Rabella, M Otegui, R Parody, JM Heck, ...
The Journal of infectious diseases 192 (6), 1061-1065, 2005
|Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults|
JV Williams, JE Crowe Jr, R Enriquez, P Minton, RS Peebles Jr, ...
The Journal of infectious diseases 192 (7), 1149-1153, 2005
|Potently neutralizing and protective human antibodies against SARS-CoV-2|
SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ...
Nature 584 (7821), 443-449, 2020
|A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin|
JC Krause, T Tsibane, TM Tumpey, CJ Huffman, CF Basler, JE Crowe
Journal of virology 85 (20), 10905-10908, 2011
|Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers|
G Fibriansah, KD Ibarra, TS Ng, SA Smith, JL Tan, XN Lim, JSG Ooi, ...
Science 349 (6243), 88-91, 2015
|A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins|
G Fibriansah, JL Tan, SA Smith, R De Alwis, TS Ng, VA Kostyuchenko, ...
Nature communications 6 (1), 1-10, 2015
|An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines|
BR Murphy, SL Hall, AB Kulkarni, JE Crowe Jr, PL Collins, M Connors, ...
Virus research 32 (1), 13-36, 1994